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S U M M A R Y
Background: AIDS mortality played an important role in the decline in syphilis prevalence in the USA, but
its effect on the dramatic reduction in syphilis prevalence in Southern and Eastern Africa has not been
explored. In this ecological study, we investigated the extent to which the relationship between syphilis
and HIV prevalence at a population level varied between the early and late periods of the HIV epidemic.
Methods: We performed linear regression analysis to measure the association between the national
prevalence of syphilis and the peak-HIV prevalence in the early and late phases of the HIV epidemic in
11 countries of Southern and Eastern Africa.
Results: Our analysis showed a strong positive association between peak-HIV prevalence and syphilis
prevalence early in the HIV epidemic (R2 = 0.59; p = 0.006). Although only of borderline statistical
signiﬁcance, this linear relationship between HIV prevalence and syphilis prevalence switched to a
negative direction late in the HIV epidemic (R2 = 0.32; p = 0.07).
Conclusions: AIDS mortality may have played an important role in the decline in syphilis in this region.
Consequently, with AIDS deaths declining in Sub-Saharan Africa, vigilant surveillance of syphilis
prevalence will be necessary to detect a potential re-emergence, as has occurred in high-income
countries, and to render a timely public health response.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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There has been a dramatic decline in the prevalence of syphilis
in Southern and Eastern Africa over the past two decades. In South
Africa, for example, the prevalence dropped from 10.8% to 1.6%
between 1998 and 2004 among women attending antenatal care.1
Two explanations for this have dominated the literature. Authors
of a paper entitled ‘‘Declining syphilis prevalence among pregnant
women in northern Botswana: an encouraging sign for the HIV
epidemic?’’ argued that reductions in higher-risk sex and the
introduction of syndromic management of sexually transmitted
infections (STIs) were responsible.2 Similar explanations were
offered in an analysis of factors responsible for the decline in
syphilis prevalence among pregnant women in Nairobi since
1995.3 In contrast, a study from the USA that applied regression
analysis to state-level AIDS mortality rates and syphilis* Corresponding author. Tel.: +27 21 404 9111; fax: +27 21 404 9113.
E-mail address: ckenyon@itg.be (C.R. Kenyon).
http://dx.doi.org/10.1016/j.ijid.2014.05.014
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).incidence rates found that AIDS mortality explained one-third
to one-half of the decline in syphilis incidence among men.4 This
can be explained by the strong association between HIV and
syphilis at the individual-level, and that people at risk for
syphilis are also at increased risk for HIV infection. In the era
preceding the availability of antiretroviral therapy (ART), a
relatively high proportion of individuals contributing to syphilis
transmission would have been co-infected with HIV and
subsequently died from AIDS. Although estimates of syphilis
and HIV co-infection were not routinely reported, AIDS
mortality could have been responsible for reducing a substan-
tial portion of syphilis transmission and overall syphilis
prevalence. Mathematical modelling of data from South Africa
suggests that increased condom usage, improved treatment of
STIs, and AIDS mortality were collectively responsible for the
decline in syphilis prevalence between 1990 and 2005.5
From a public health perspective, it is important to establish
which of these three factors may have produced the greatest
reductions in syphilis prevalence in Southern and Eastern Africa. Ifciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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impact, then recent suggestions are plausible that syphilis
prevalence should remain low in future years and that syphilis
is a reasonable candidate for elimination in the region.6 However, if
AIDS mortality played a key role in reducing the population
prevalence of syphilis, then the comparatively recent and
widespread implementation of ART in the region may lead to a
concomitant resurgence of syphilis. Since HIV has become a
chronic disease that is manageable by ART in high-income
countries, syphilis incidence has increased sharply, particularly
among men who have sex with men.7 This has been due to a
number of factors including reduced AIDS mortality, behavioural
disinhibition, and other factors.8,9
We used ecological regression analyses to test the hypothesis
that AIDS mortality was an important driver of the decline in
syphilis prevalence in Southern and Eastern Africa. Underlying our
methodology is the hypothesis that if AIDS mortality has
contributed to reductions, then areas with a higher peak-HIV
prevalence should have experienced a more rapid and profound
decline in syphilis incidence and prevalence than otherwise might
have occurred. Thus, we compare the association between syphilis
and HIV prevalence at a national level before and after the period of
peak-HIV prevalence.
2. Methods
2.1. Syphilis prevalence data
National syphilis prevalence estimates were taken from sources
as detailed in Table 1. We used national antenatal surveys
wherever possible. However, to our knowledge there are no
national antenatal survey data available for a number of countries,
particularly from the early years of the HIV epidemic. In these
cases, we drew data from antenatal surveys conducted from
geographic regions within countries that had mainly been
identiﬁed in two systematic reviews. One was a systematic review
of the prevalence of malaria and curable STIs among pregnant
women attending antenatal care in Sub-Saharan Africa between
1990 and 2011;10 this review excluded South Africa where malaria
is no longer endemic. The other was a systematic review of STI
prevalence in South Africa between 1985 and 2003 in selected
sentinel populations.11 We only used prevalence estimates from
antenatal surveys in these systematic reviews. Antenatal data from
additional sources were drawn from Botswana, Lesotho, Kenya,
Malawi, and Tanzania. Further details for all sources are provided
in Table 1. In addition, prevalence estimates were taken from
several nationally representative surveys conducted in Uganda
(2005 and 2011)12,13 and Madagascar (2003).14 These surveys
provided syphilis prevalence estimates among 15–49-year-old
women. Syphilis prevalence data from earlier in Uganda’s HIV
epidemic were obtained from two studies.15,16 Because the ﬁrst of
these two studies (1993 estimates) reported combined estimates
for men and women, these were only used for the graphical
representation of syphilis prevalence over time in Uganda and not
in the calculation of syphilis prevalence from before the peak-HIV
prevalence. The second study (1998 estimate) employed a
population-based sampling strategy; these estimates for women
were used as the pre-peak HIV syphilis prevalence.
A number of prevalence estimates were obtained from the
World Health Organization’s Global Data Repository, which has
been an important source of national antenatal syphilis prevalence
estimates since 2008.17 Insufﬁcient data were found for Burundi,
Rwanda, and Swaziland to warrant their inclusion in our study. In
total, data from 11 countries were used to calculate the following
variables: (1) ‘Peak-HIV prevalence’ deﬁned as the highest HIV
prevalence in the relevant area (country or province) between1990 and 2009. The utility of peak HIV prevalence as a means of
comparing different HIV epidemics has been detailed else-
where.18,19 (2) ‘Pre-peak-HIV syphilis prevalence’ deﬁned as the
syphilis prevalence in the country from the ﬁrst year this was
measured. (3) ‘Post-peak-HIV syphilis prevalence’ deﬁned as the
nadir of syphilis prevalence reached in the period after the year
that HIV prevalence reached its peak prevalence. (4) ‘Change in
syphilis prevalence’ deﬁned as the absolute difference (in
percentage terms) between the mean syphilis prevalence in the
period before the year that HIV reached its peak prevalence in that
country and the mean syphilis prevalence in the post-peak-HIV
period.
2.2. HIV prevalence data
We obtained country- and year-speciﬁc 15–49-year-old HIV
prevalence estimates from UNAIDS for the period 1990–2010
(http://www.unaids.org/en/dataanalysis/knowyourepidemic).
2.3. Statistical analyses
We performed linear regression to analyze the relationship
between syphilis prevalence and peak-HIV prevalence, and applied
Pearson’s correlation coefﬁcient (R2) to measure the proportion of
explainable variance. Analyses were performed using Stata 12.1
(StataCorp LP, College Station, TX, USA).
3. Results
As shown in Figure 1, the only country not to experience a drop
in syphilis prevalence during this time period was Madagascar,
which was also the only country in Southern and Eastern Africa
without a generalized HIV epidemic. The other 10 countries of our
analysis experienced a decline in syphilis that occurred at some
point after the onset of the HIV epidemic in the country. In one-half
of these countries, syphilis prevalence declined within 10 years of
HIV prevalence reaching 1% (Botswana, Lesotho, Kenya, Malawi,
and South Africa), whereas in the remaining countries, syphilis
declined some time later (Mozambique, Tanzania, Uganda, Zambia,
and Zimbabwe).
There was a strong positive association between the syphilis
prevalence (pre-peak-HIV) and the peak-HIV prevalence at a
country level (R2 = 0.59; p = 0.006; see Figure 2a). Although only of
borderline statistical signiﬁcance, the linear relationship between
HIV prevalence and syphilis prevalence switched to a negative
direction when peak-HIV prevalence was related to post-peak-HIV
syphilis prevalence (R2 = 0.32; p = 0.07; Figure 2b). There was also
a statistically signiﬁcant positive association between peak-HIV
prevalence and the change in syphilis prevalence (R2 = 0.85;
p = 0.0001; Figure 2c).
4. Discussion
The syndromic management of STIs was introduced into all
countries of Southern and Eastern Africa in the late 1990s. There is
no evidence we could ﬁnd that the method was less effectively
implemented in Madagascar than elsewhere.20 Madagascar is the
only country in the region not to have experienced a generalized
HIV epidemic or a decline in syphilis prevalence. One possible
explanation is that AIDS mortality played an important role in the
decline in syphilis prevalence rates. This is also a plausible
interpretation for the observed shift in the relationship between
syphilis and HIV prevalence at the country level, from a positive
association early in the HIV epidemic to a negative association late
in the HIV epidemic. This suggests that countries with higher peak
HIV prevalence rates had greater declines in syphilis prevalence. As
Table 1
Sources of syphilis prevalence data
Country Year of sampling Study design, testing modality and study reference
Botswana 1992–2003 Consecutive sample of 750 pregnant women per year (1992–2003) attending any one of Francistown’s antenatal care sites.
Francistown is Botswana’s second biggest town. Approximately 3500 deliveries per year occur in Francistown healthcare
facilities, and more than 95% of pregnant women have at least one visit for antenatal care. Syphilis testing with
VDRL test only2
2008–2011 WHO Global Health Observatory Data Repository17
Kenya 1992–1997 81 311 pregnant women from 10 antenatal sentinel sites in Nairobi were screened for syphilis on their ﬁrst
antenatal visit using the RPR only3
2008–2011 WHO Global Health Observatory Data Repository17
Lesotho 1995 Random sample of 190 women from a rural area of Lesotho. Syphilis testing using RPR and TPHA tests33
2003–2007 Data from three national antenatal surveys that assessed syphilis prevalence were used. The 2003 survey tested
2666 pregnant women aged 15–49 years from six sites around the country. They were all tested for syphilis with an RPR
test only during their ﬁrst visit to the antenatal clinic between July and October 2003. Surveys in 2005 and 2007 used the
same methodology excluding the fact that they sampled at 10 sites, and in 2005 and 2007, 4542 and 4657 women
were tested, respectively34
2010 WHO Global Health Observatory Data Repository17
Madagascar 2003 As part of the 2003 Demographic and Health Survey, a nationally representative sample of 2783 women age 15–49 years
were tested for syphilis with an RPR test only14
2008–2011 WHO Global Health Observatory Data Repository17
Malawi 1990, 1993–1994,
and 1996
Three major surveys carried out in 1990, 1993, and 1994 and a smaller survey sample of women in 1996 for a total sample
of 10 401 consecutive ﬁrst-visit pregnant women visiting antenatal care facilities in Blantyre. Syphilis was tested using
RPR and TPHA or FTA testing35
1990 and 1993 Two surveys conducted in Blantyre sampling 9890 ﬁrst-visit pregnant women. Syphilis was tested using RPR and TPHA
or FTA testing36
2000–2004 Cross-sectional study of 3824 pregnant women in Blantyre. Syphilis tested using RPR and TPHA tests37
2004–2005 2297 pregnant women recruited in three rural and one peri-urban antenatal clinic in southern Malawi as a part of the APPLe
study (Azithromycin for the Prevention of Preterm Labor). Syphilis screening with VDRL only38
2005 All pregnant women (n = 8953) attending antenatal clinics for the ﬁrst time in the month of August at 19 sites in Malawi
were tested for syphilis with the Abbott Determine Rapid Syphilis TP assay39
2008–2011 WHO Global Health Observatory Data Repository17
Mozambique 1991–1992 Cross-sectional study among 201 pregnant women and 162 patients presenting with genital complaints. Syphilis
testing with RPR and TPHA40
1992–1993 Cross-sectional study conducted among 1728 consecutive antenatal attendees at 14 rural clinics in Zambe´zia. Syphilis
testing with RPR and MHA-TP41
2000 Age-stratiﬁed cross-sectional study recruiting 262 women in rural southern Mozambique. Syphilis testing with RPR and IgG
ELISA42
2003–2004 Study of 4789 women attending their ﬁrst antenatal visit at six health facilities in Sofala Province, central Mozambique.
Compared the sensitivity of the immunochromatographic strip (ICS) and RPR test43
2003–2005 1030 pregnant women recruited at an antenatal clinic in Manhic¸a District, southern Mozambique. Syphilis testing with RPR
only44
2004 Cross-sectional study conducted among 1119 women attending antenatal care clinics in Tete Province. Syphilis testing with
RPR and TPHA45
2008–2011 WHO Global Health Observatory Data Repository17
South Africa 1990–1996 Johnson et al. systematic review11
1996–2011 National antenatal surveys46–51
Tanzania 1992–2006 National antenatal surveys52,53
2008–2011 WHO Global Health Observatory Data Repository17,54
Uganda 1993 A population-based survey of persons aged 15 years or older in two villages in Masaka, Uganda; 294 men and women were
tested with both RPR and a TPHA. Reported results are for those who tested positive on both tests15
1990–1993 A cross-sectional survey of all 15–54-year-old inhabitants of 15 neighbouring villages in rural south-western Uganda;
538 women were tested for syphilis with RPR and TPHA conﬁrmatory testing16
2004 250 pregnant women recruited for study in Entebbe, Uganda. Syphilis testing with RPR and TPHA55
2005 A nationally representative sample of 9079 women aged 15–49 years were tested for syphilis with an RPR test and a
conﬁrmatory TPHA test13
2011 A nationally representative sample of 10 794 women aged 15–49 years were tested for syphilis with the Bioline syphilis
rapid diagnostic test. Those who tested positive had an RPR test to assess for active syphilis. Results reported are for those
who tested positive for both tests12
Zambia 1994–2008 National antenatal surveys56
2008–2011 WHO Global Health Observatory Data Repository17
Zimbabwe 1991 1433 pregnant women included in a study conducted in Umzingwane District. Syphilis testing with RPR test only57
Not reported Pregnant women recruited for cross-sectional study in Gutu District of Zimbabwe. Syphilis testing with RPR test only58
Not reported Random sampling of 2969 pregnant women at Harare Maternity Hospital, Harare. Syphilis testing with RPR and TPHA59
2002–2003 Cross-sectional study of 691 pregnant women. Study was conducted from three peri-urban clinics around Harare. Syphilis
testing with RPR and TPHA60
2002–2004 Cross-sectional study that enrolled pregnant women in Harare (n = 691) and Moshi (n = 2654). Syphilis testing with
RPR and Determine Syphilis TP61
2011 WHO Global Health Observatory Data Repository17
VDRL, Venereal disease research laboratory; WHO, World Health Organization; RPR, rapid plasma reagin; TPHA, Treponema pallidum hemagglutination assay; FTA,
Fluorescent Treponemal antibody-absorption test; MHA-TP, micro-hemagglutination assay–Treponema pallidum; IgG, Immunoglobulin G; ELISA, enzyme-linked
immunosorbent assay.
C.R. Kenyon et al. / International Journal of Infectious Diseases 29 (2014) 54–6156observed in the USA, AIDS mortality could have been responsible
for this effect in Southern and Eastern Africa. The effect of AIDS
mortality could have been mediated via three pathways: (1)
individuals most at risk of syphilis acquisition and transmissionwere removed from the population; (2) people living in areas with
higher AIDS mortality may have been more likely to change their
sexual behaviour;4,21 and (3) depletion of the pool of high-risk
persons might have made it difﬁcult for the remaining high-risk
Figure 1. National prevalence of syphilis and HIV by year in 11 countries of Southern and Eastern Africa (data sources detailed in the Methods section).
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sex.22
Another potential interpretation of our ﬁndings is that optimal
STI treatment was more effectively provided in countries withhigher peak HIV prevalence estimates. However, an analysis using
a number of data sources as proxy measures for the efﬁcacy of STI
treatment showed there to be no relationship between peak-HIV
prevalence and STI treatment efﬁcacy.23 Alternatively, it is possible
Fig. . (Continued ).
C.R. Kenyon et al. / International Journal of Infectious Diseases 29 (2014) 54–6158that countries more heavily affected by HIV also responded more
rapidly to the epidemic, thereby accelerating reductions in higher-
risk sex within their borders. However, we could ﬁnd scant
evidence to support this theory. Analysis of changes in riskbehaviour in South Africa’s ethnic groups, for example, suggests
that ethnic groups most affected by HIV also showed a more rapid
increase in condom usage, but this did not translate into lower HIV
prevalence because there was little change in their rates of
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Figure 2. Association between national peak-HIV prevalence and syphilis prevalence from (a) early in the HIV epidemic (pre-peak) and (b) late in the epidemic (post-peak),
and (c) the absolute change in syphilis prevalence between the pre- and post-peak-HIV periods in the countries of Southern and Eastern Africa. The data sources are described
in the Methods section.
C.R. Kenyon et al. / International Journal of Infectious Diseases 29 (2014) 54–61 59multiple and concurrent partnering, which remained considerably
higher than among groups with a low prevalence of HIV.24 Thirdly,
the declines in syphilis prevalence may be due to some other
unmeasured variable. The reasons behind the declines in syphilis
prevalence are likely to be multifactorial and to vary somewhat
among countries. This may explain the ﬁnding that in some
countries syphilis prevalence declined relatively soon after the HIV
epidemic began whereas in others it declined some time later.
There are a number of limitations with this analysis. The main
problem is the paucity of accurate representative syphilis
prevalence data. This is particularly the case in the 1980s and
1990s. We were thus forced in a number of instances to use data
that were derived from local surveys that are unlikely to reﬂect
national populations. Thus, our country-level ﬁndings of a positive
relationship between peak-HIV prevalence and pre-peak-HIV
syphilis prevalence should be interpreted with caution. However,
it should be noted that syphilis prevalence estimates from surveys
conducted prior to the peak of HIV were all high (4%) and
considerably lower following the peak-HIV period. This is in
keeping with the ﬁndings of the systematic review of curable STIs
among pregnant women attending antenatal care facilities in Sub-
Saharan Africa and the World Health Organization reports on this
topic.10,25,26Since HIV is one of a number of causes of a false-positive
diagnosis using rapid plasma reagin (RPR) assays, the HIV epidemic
could have inﬂuenced RPR-based estimates of syphilis preva-
lence.27 However, the fact that the syphilis prevalence dropped
rather than rose as HIV prevalence increased suggests that this was
unlikely to have played a large role. RPR results can also vary by a
one-dilution titre between different batches, which adds a further
potential misclassiﬁcation bias.28 The endemic treponematoses –
yaws, bejel, and pinta – are other possible causes of false-positives
with all the testing algorithms used in the studies. Thus, observed
declines in syphilis prevalence may have been an artefact of
reductions in these other treponematoses. This is however most
unlikely, as none of the countries investigated here had reported
any of these diseases between 1980 and 2012.29
A further reason we do not believe our results are a chance
ﬁnding is that we have found the same association between
syphilis and peak-HIV prevalence at a provincial level in South
Africa and Zambia and at a district council level in South Africa. In
each of these studies we found the same positive relationship
between syphilis prevalence early in the HIV epidemic and peak-
HIV epidemic and a negative relationship between syphilis
prevalence late in the HIV epidemic and peak-HIV prevalence
(C. Kenyon; unpublished results).
C.R. Kenyon et al. / International Journal of Infectious Diseases 29 (2014) 54–6160There has been a commendable reduction in syphilis prevalence
in almost all the countries in this region. The data presented here,
however, add to evidence from elsewhere that AIDS mortality
likely played a signiﬁcant role in this decline. The widespread
availability of ART in high-income countries has indirectly
contributed to a resurgence of syphilis in such settings through
a combination of reduced AIDS mortality and behavioural
disinhibition.30 Both of these factors have been noted in Southern
and Eastern Africa.31,32 Vigilant surveillance is therefore necessary
to detect a potential re-emergence of syphilis prevalence, as
observed in high-income countries, and to render a timely public
health response.
Conﬂict of interest: None declared.
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